Investor directory

SOPHiA GENETICS

SOPHiA GENETICS is a healthcare technology company specializing in data-driven medicine. It offers the SOPHiA DDM™ Platform, a cloud-based SaaS solution that analyzes complex multimodal datasets from various diagnostic modalities to generate insights. With over 780 global clients, including hospitals, laboratories, and biopharma institutions across three continents, the company aims to make data-driven medicine the standard of care in healthcare and life sciences research.

Top Stages

Acquisition
http://sophiagenetics.com
https://crunchbase.com/organization/sophia-genetics
https://facebook.com/sophiagenetics
https://linkedin.com/company/sophiagenetics
https://twitter.com/sophiagenetics
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=237555193

George Cardoza

CFO

1 past transactions

Interactive Biosoftware

Acquisition in 2018
Interactive Biosoftware, founded in April 2007 and based in Rouen, France, specializes in developing software applications for the human genetics field, catering to clinical and research scientists globally. The company focuses on creating practical tools for healthcare and life sciences, particularly in molecular biology. Its flagship product, Alamut Batch, launched in 2012, serves as a high-throughput annotation engine for genetic variants, providing valuable data, especially in RNA splicing. Interactive Biosoftware aims to equip geneticists and researchers with sophisticated, user-friendly, and reliable software solutions to facilitate genetic analysis, surveillance, and the sharing of information across various tiers of human genome research. As of June 2018, it operates as a subsidiary of SOPHiA GENETICS SA.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.